Loading market dashboard
Lexeo Therapeutics, Inc. Common Stock
LXEOHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Lexeo Therapeutics, Inc. Common Stock · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $589.30M | $589.30M - $589.30M | $117.86M | $2.998 | 3 |
| Dec 2029 | $300.32M | $300.32M - $300.32M | $60.06M | $0.722 | 5 |
| Dec 2028 | $92.50M | $92.49M - $92.50M | $18.50M | -$0.705 | 6 |
| Dec 2027 | $8.63M | $8.63M - $8.63M | $1.72M | -$1.259 | 6 |
| Dec 2026 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.17 | 0 |
| Dec 2025 | $1.13M | $1.13M - $1.13M | $225.0K | -$1.945 | 5 |
| Dec 2024 | $4.50M | $4.50M - $4.50M | $900.0K | -$3.12 | 3 |